Kindy M - Search Results

1

Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Younkin SG. Ertekin-Taner N, et al. Among authors: kindy m. Hum Mol Genet. 2005 Feb 1;14(3):447-60. doi: 10.1093/hmg/ddi041. Epub 2004 Dec 22. Hum Mol Genet. 2005. PMID: 15615772

2

Abeta deposition is essential to AD neuropathology.

Estus S, Borchelt D, Kindy MS, Vassar R. Estus S, et al. J Alzheimers Dis. 2002 Jun;4(3):133-8. doi: 10.3233/jad-2002-4302. J Alzheimers Dis. 2002. PMID: 12226531 No abstract available.

3

Neprilysin regulates amyloid Beta peptide levels.

Marr RA, Guan H, Rockenstein E, Kindy M, Gage FH, Verma I, Masliah E, Hersh LB. Marr RA, et al. Among authors: kindy m. J Mol Neurosci. 2004;22(1-2):5-11. doi: 10.1385/JMN:22:1-2:5. J Mol Neurosci. 2004. PMID: 14742905

4

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E. Marr RA, et al. Among authors: kindy ms. J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003. J Neurosci. 2003. PMID: 12657655 Free PMC article.

5

Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.

Lauderback CM, Hackett JM, Keller JN, Varadarajan S, Szweda L, Kindy M, Markesbery WR, Butterfield DA. Lauderback CM, et al. Among authors: kindy m. Biochemistry. 2001 Feb 27;40(8):2548-54. doi: 10.1021/bi002312k. Biochemistry. 2001. PMID: 11327877

6

Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice.

Keller JN, Lauderback CM, Butterfield DA, Kindy MS, Yu J, Markesbery WR. Keller JN, et al. Among authors: kindy ms. J Neurochem. 2000 Apr;74(4):1579-86. doi: 10.1046/j.1471-4159.2000.0741579.x. J Neurochem. 2000. PMID: 10737615 Free article.

7

Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein.

Hook VY, Kindy M, Reinheckel T, Peters C, Hook G. Hook VY, et al. Among authors: kindy m. Biochem Biophys Res Commun. 2009 Aug 21;386(2):284-8. doi: 10.1016/j.bbrc.2009.05.131. Epub 2009 Jun 6. Biochem Biophys Res Commun. 2009. PMID: 19501042 Free PMC article.

8

Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.

Hook V, Hook G, Kindy M. Hook V, et al. Among authors: kindy m. Biol Chem. 2010 Aug;391(8):861-72. doi: 10.1515/BC.2010.110. Biol Chem. 2010. PMID: 20536395 Free PMC article. Review.

9

Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease.

Hook V, Kindy M, Hook G. Hook V, et al. Among authors: kindy m. Biol Chem. 2007 Feb;388(2):247-52. doi: 10.1515/BC.2007.027. Biol Chem. 2007. PMID: 17261088

10

Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics.

Hook G, Hook VY, Kindy M. Hook G, et al. Among authors: kindy m. Biol Chem. 2007 Sep;388(9):979-83. doi: 10.1515/BC.2007.117. Biol Chem. 2007. PMID: 17696783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page